Peer-reviewed veterinary case report
Overview of genetically engineered mouse models of colorectal carcinoma to enable translational biology and drug development.
- Journal:
- Current protocols in pharmacology
- Year:
- 2014
- Authors:
- Roper, Jatin et al.
- Affiliation:
- Division of Gastroenterology and Molecular Oncology Research Institute · United States
Abstract
Preclinical models for colorectal cancer (CRC) are critical for translational biology and drug development studies to characterize and treat this condition. Mouse models of human cancer are particularly popular because of their relatively low cost, short life span, and ease of use. Genetically engineered mouse models (GEMMs) of CRC are engineered from germline or somatic modification of critical tumor suppressor genes and/or oncogenes that drive mutations in human disease. Detailed in this overview are the salient features of several useful colorectal cancer GEMMs and their value as tools for translational biology and preclinical drug development.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/24934606/